BOSTON, Aug. 18, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., a medical technology company committed to redefining the standard of care for lumbar discectomy patients with large annular defects ...
BOSTON, Oct. 24, 2024 /PRNewswire/ -- Intrinsic Therapeutics, Inc., a medical device company focused on preventing reherniation and reoperation following lumbar discectomy to treat herniated discs, ...
Spinol Medicalâ„¢ today announced the advancement of its OctaSealâ„¢ Annular Closure System into U.S. FDA review. OctaSeal represents a novel, tubular-based, intradiscal technology designed to close ...